Objective: To investigate the effect of risk management combined with intraoperative precision care on the efficacy and safety of interventional embolization therapy for elderly patients with cerebral aneurysms. Methods: In this prospective randomized controlled study, we included 60 elderly patients with cerebral aneurysm treated with interventional embolization. The patients were randomly divided into an experiment group (n=30) and a control group (n=30). The control group received conventional care during the interventional procedure, while the experiment group received risk management combined with precision care. The outcome of the procedure, time to disappearance of clinical symptoms, length of hospitalization, incidence of complications, neurological function and quality of life before and 3 months after the procedure in both groups were assessed and compared. Results: Compared with the control group, the experiment group had significantly less intraoperative bleeding, shorter operative time (all P<0.001), shorter time to disappearance of clinical symptoms and shorter hospitalization (all P<0.001), and a lower rate of surgical complications (P<0.05). Three months after the operation, the experiment group had better neurological function and quality of life, with significantly lower mRs scores (modified Rankin scale), NIHSS (National Institute of Health Stroke Scale) and higher SF-36 scores (MOS item short from health survey) than those of the control group (both P<0.001). Conclusion: Risk management combined with precision care can effectively improve the surgical safety of interventional embolization in elderly patients with cerebral aneurysm, reduce the incidence of surgical complications, and thus improve the prognosis.